메뉴 건너뛰기




Volumn 36, Issue 11, 2009, Pages 732-734

Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis

Author keywords

[No Author keywords available]

Indexed keywords

BORIC ACID; METRONIDAZOLE; TINIDAZOLE;

EID: 70350765090     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181b08456     Document Type: Article
Times cited : (97)

References (12)
  • 1
    • 33845945332 scopus 로고    scopus 로고
    • Prevalence of bacterial vaginosis 2001-2004 National Health and Nutrition Examination Survey data
    • Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109:114-120.
    • (2007) Obstet Gynecol , vol.109 , pp. 114-120
    • Allsworth, J.E.1    Peipert, J.F.2
  • 2
    • 35748980559 scopus 로고    scopus 로고
    • Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting
    • Evans AL, Scally AJ, Wellard SJ, et al. Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting. Sex Transm Infect 2007; 83:470-475.
    • (2007) Sex Transm Infect , vol.83 , pp. 470-475
    • Evans, A.L.1    Scally, A.J.2    Wellard, S.J.3
  • 3
    • 20444439551 scopus 로고    scopus 로고
    • What's new in bacterial vaginosis and trichomoniasis?
    • Sobel JD. What's new in bacterial vaginosis and trichomoniasis? Infect Dis Clin North Am 2005; 19:387-406.
    • (2005) Infect Dis Clin North Am , vol.19 , pp. 387-406
    • Sobel, J.D.1
  • 4
    • 0001620751 scopus 로고    scopus 로고
    • Recurrent bacterial vaginosis
    • Hay P. Recurrent bacterial vaginosis. Curr Infect Dis Rep 2000; 2:506-512.
    • (2000) Curr Infect Dis Rep , vol.2 , pp. 506-512
    • Hay, P.1
  • 5
    • 33646942950 scopus 로고    scopus 로고
    • High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence
    • Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193:1478-1486.
    • (2006) J Infect Dis , vol.193 , pp. 1478-1486
    • Bradshaw, C.S.1    Morton, A.N.2    Hocking, J.3
  • 6
    • 1242292259 scopus 로고    scopus 로고
    • Managing recurrent bacterial vaginosis
    • Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004; 80:8-11.
    • (2004) Sex Transm Infect , vol.80 , pp. 8-11
    • Wilson, J.1
  • 7
    • 33646118730 scopus 로고    scopus 로고
    • Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis
    • Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194:1283-1289.
    • (2006) Am J Obstet Gynecol , vol.194 , pp. 1283-1289
    • Sobel, J.D.1    Ferris, D.2    Schwebke, J.3
  • 8
    • 16544371888 scopus 로고    scopus 로고
    • Treatment of recurrent bacterial vaginosis with tinidazole
    • Baylson FA, Nyirjesy P, Weitz MV. Treatment of recurrent bacterial vaginosis with tinidazole. Obstet Gynecol 2004; 104: 931-932.
    • (2004) Obstet Gynecol , vol.104 , pp. 931-932
    • Baylson, F.A.1    Nyirjesy, P.2    Weitz, M.V.3
  • 10
    • 37349022421 scopus 로고    scopus 로고
    • An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole
    • Swidsinski A, Mendling W, Loening-Baucke V, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 2008; 198:97.
    • (2008) Am J Obstet Gynecol , vol.198 , pp. 97
    • Swidsinski, A.1    Mendling, W.2    Loening-Baucke, V.3
  • 11
    • 0020665888 scopus 로고
    • Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations
    • Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
    • (1983) Am J Med , vol.74 , pp. 14-22
    • Amsel, R.1    Totten, P.A.2    Spiegel, C.A.3
  • 12
    • 58849135784 scopus 로고    scopus 로고
    • Antifungal mechanisms supporting boric acid therapy of Candida vaginitis
    • De Seta F, Schmidt M, Vu B, et al. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J. Antimicrob Chemother 2009; 63:325-336.
    • (2009) J. Antimicrob Chemother , vol.63 , pp. 325-336
    • De Seta, F.1    Schmidt, M.2    Vu, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.